Condition
Lung Cancer
Estimated Enrollment: 18
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: 12-169
Study First Received: January 9, 2013
Last Updated: January 27, 2017
Estimated Primary Completion Date: January 2018
Primary Outcome Measures:
Maximum Tolerated Dose (MTD)|safety|detection of virus in body fluids|evaluation of viral appearance in tumor|Therapeutic efficacy
Sponsors and Collaborators:
Memorial Sloan Kettering Cancer Center|Genelux Corporation
Website Link: https://ClinicalTrials.gov/show/NCT01766739
